NCT06887010View on ClinicalTrials.gov

A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

September 16, 2025

Study Completion Date

September 16, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

ABBV-101

Oral: Tablet

Trial Locations (1)

60030

Acpru /Id# 275921, Grayslake

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY